IL129478A0 - Polypeptides comprising gax protein domains involved in repressing transcription and/or interacting with other proteins corresponding nucleic acids and their use - Google Patents

Polypeptides comprising gax protein domains involved in repressing transcription and/or interacting with other proteins corresponding nucleic acids and their use

Info

Publication number
IL129478A0
IL129478A0 IL12947897A IL12947897A IL129478A0 IL 129478 A0 IL129478 A0 IL 129478A0 IL 12947897 A IL12947897 A IL 12947897A IL 12947897 A IL12947897 A IL 12947897A IL 129478 A0 IL129478 A0 IL 129478A0
Authority
IL
Israel
Prior art keywords
polypeptides
interacting
nucleic acids
protein domains
corresponding nucleic
Prior art date
Application number
IL12947897A
Other languages
English (en)
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of IL129478A0 publication Critical patent/IL129478A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • C07K14/4703Inhibitors; Suppressors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/04Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/70Nanostructure
    • Y10S977/788Of specified organic or carbon-based composition
    • Y10S977/797Lipid particle
    • Y10S977/798Lipid particle having internalized material
    • Y10S977/799Containing biological material
    • Y10S977/80Nucleic acid, e.g. DNA or RNA
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/902Specified use of nanostructure
    • Y10S977/904Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/915Therapeutic or pharmaceutical composition

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IL12947897A 1996-10-18 1997-10-16 Polypeptides comprising gax protein domains involved in repressing transcription and/or interacting with other proteins corresponding nucleic acids and their use IL129478A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9612730A FR2754822B1 (fr) 1996-10-18 1996-10-18 Polypeptides comprenant des domaines de la proteine gax, impliques dans la repression de transcription et/ou interagissant avec d'autres proteines, acides nucleiques correspondants et leurs utilisations
PCT/FR1997/001850 WO1998017686A1 (fr) 1996-10-18 1997-10-16 Polypeptides comprenant des domaines de la proteine gax, impliques dans la repression de transcription et/ou interagissant avec d'autres proteines, acides nucleiques correspondants et leurs utilisations

Publications (1)

Publication Number Publication Date
IL129478A0 true IL129478A0 (en) 2000-02-29

Family

ID=9496803

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12947897A IL129478A0 (en) 1996-10-18 1997-10-16 Polypeptides comprising gax protein domains involved in repressing transcription and/or interacting with other proteins corresponding nucleic acids and their use

Country Status (22)

Country Link
US (1) US6121005A (ru)
EP (1) EP0941243A1 (ru)
JP (1) JP2001503615A (ru)
KR (1) KR20000049249A (ru)
CN (1) CN1237980A (ru)
AP (1) AP9901510A0 (ru)
AU (1) AU741586B2 (ru)
BG (1) BG63548B1 (ru)
BR (1) BR9711947A (ru)
CA (1) CA2268045A1 (ru)
CZ (1) CZ131899A3 (ru)
EA (1) EA003694B1 (ru)
FR (1) FR2754822B1 (ru)
HU (1) HUP9903956A3 (ru)
IL (1) IL129478A0 (ru)
NO (1) NO991830L (ru)
NZ (1) NZ335283A (ru)
OA (1) OA11034A (ru)
PL (1) PL332874A1 (ru)
SK (1) SK51199A3 (ru)
WO (1) WO1998017686A1 (ru)
ZA (1) ZA979390B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001289652A1 (en) * 2000-06-28 2002-01-08 Aventis Pharma S.A. Compositions and methods for regulating the cell cycle using a ki gene or polypeptide
US8124598B2 (en) 2006-09-14 2012-02-28 Sharon Sageman 7-keto DHEA for psychiatric use
US20100160274A1 (en) * 2007-09-07 2010-06-24 Sharon Sageman 7-KETO DHEA for Psychiatric Use
US20130059773A1 (en) * 2010-02-24 2013-03-07 Veronique Witko-Sarsat Compounds for the treatment of inflammation and neutropenia

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856121A (en) * 1994-02-24 1999-01-05 Case Western Reserve University Growth arrest homebox gene
US5554181A (en) * 1994-05-04 1996-09-10 Regents Of The University Of Minnesota Stent
GB9422175D0 (en) * 1994-11-03 1994-12-21 Univ Dundee Indentification of the p21 waf1-pcna interaction site and therapeutic applications thereof
FR2732357B1 (fr) * 1995-03-31 1997-04-30 Rhone Poulenc Rorer Sa Vecteurs viraux et utilisation pour le traitement des desordres hyperproliferatifs, notamment de la restenose
FR2740344B1 (fr) * 1995-10-31 1997-11-21 Rhone Poulenc Rorer Sa Application de la proteine gax au traitement de cancers

Also Published As

Publication number Publication date
EA003694B1 (ru) 2003-08-28
WO1998017686A1 (fr) 1998-04-30
BR9711947A (pt) 1999-08-24
BG63548B1 (bg) 2002-04-30
AU741586B2 (en) 2001-12-06
CN1237980A (zh) 1999-12-08
SK51199A3 (en) 2000-04-10
EP0941243A1 (fr) 1999-09-15
ZA979390B (en) 1998-05-12
PL332874A1 (en) 1999-10-25
NO991830L (no) 1999-06-16
JP2001503615A (ja) 2001-03-21
US6121005A (en) 2000-09-19
NZ335283A (en) 2001-02-23
AP9901510A0 (en) 1999-06-30
NO991830D0 (no) 1999-04-16
FR2754822A1 (fr) 1998-04-24
HUP9903956A3 (en) 2002-01-28
EA199900387A1 (ru) 1999-10-28
BG103342A (en) 2000-05-31
CA2268045A1 (fr) 1998-04-30
HUP9903956A2 (hu) 2000-03-28
KR20000049249A (ko) 2000-07-25
AU4871397A (en) 1998-05-15
OA11034A (fr) 2003-03-06
FR2754822B1 (fr) 1998-11-27
CZ131899A3 (cs) 1999-07-14

Similar Documents

Publication Publication Date Title
PT2233498E (pt) Proteínas de inibição de calicreína de domínio kunitz e ácidos nucleicos que as codificam
AU6402694A (en) Methods and materials relating to the functional domains of dna binding proteins
IL136216A0 (en) Polypeptides and nucleic acids encoding the same
EP0704532A3 (en) Recombinant chimeric proteins and methods of using them
EP0948651A4 (en) RECOMBINANT N-SMASES AND NUCLEIC ACIDS ENCODING THEM
GB9310472D0 (en) Phenylalanine-free protein and dna coding thereof
GB9705903D0 (en) VP22 Proteins and uses thereof
AU1448295A (en) Assay employing both protein and antibody
IL118375A0 (en) Rhesus OB protein and DNA
EP0786001A4 (en) CHEMOKIN-LIKE PROTEINS AND THEIR USE
IL107880A (en) Galectin-8 and galectin-8-like proteins and DNA molecules coding therefor
AU6649698A (en) Peptide probes to coil proteins and methods for making the same
ID21034A (id) Protein kinase dan penggunaannya
ID24914A (id) Protein-protein pengikat peptida b-amiloid dan polinukleotida yang menuliskan kode protein tersebut
IL129478A0 (en) Polypeptides comprising gax protein domains involved in repressing transcription and/or interacting with other proteins corresponding nucleic acids and their use
ZA894800B (en) Proteins and nucleic acids
AU3432699A (en) Polypeptide domains capable of binding rho protein and their use in assays
AU8957091A (en) Immunoglobulin-binding proteins and recombinant dna molecules coding therefor
EP1029034A4 (en) PROTEINS CONTAINING SIGNAL PEPTIDE AND THEIR USE
IL120704A0 (en) Flea protease proteins nucleic acid molecules and uses thereof
AU7969091A (en) Determination of polypeptides and proteins in solutions and biological fluids
AU1614099A (en) Novel genes encoding proteins involved in mitotic checkpoint control and methodsof use thereof
EP1012160A4 (en) TANGO-72 AND TANGO-77 NUCLEIC ACID AND POLYPEPTID MOLECULES
AU9790398A (en) Mrit family of cell death proteins, nucleic acids encoding same, and methods of use
GB9512092D0 (en) Proteins and nucleic acids